Skip to Main Content
Our specialists
Find specialists supported by world-renowned researchers & educators.
See our specialists
Where to find us
See a map of Clinic Locations
Clinical Locations
Information for referring doctors
Refer a patient

Clinical Programs

At Yale Urology, our surgeons care for patients with a wide variety of conditions, from the most common to the most complicated urologic problems. We offer our patients comprehensive programs in a broad range of subspecialties including oncology, infertility, pediatrics, neuro-urology and female urology, the management of stone disease and minimally invasive surgery. The department makes substantial contributions to research and education in urology, ensuring that patients have access to cutting-edge methodologies and the latest clinical findings.

Our urologists have developed clinical expertise in one or more sub-specialties to provide comprehensive treatment of the most complex urological problems which can include:
  • Urologic oncology, including cancer of the bladder, prostate, testis, kidney, and penis
  • Kidney stone prevention and treatment, including extracorporeal shock wave lithotripsy (ESWL), nutrition counseling and medical management
  • Neuro and female urology, providing care for voiding dysfunction, incontinence, female urologic problems, and urinary tract difficulties related to neurologic diseases
  • Treatment of male infertility, addressed with microsurgical and minimally-invasive techniques for conditions such as varicoceles, obstruction of the vas deferens or epididymis, and dysfunction of sperm maturation

Our urologists use laparoscopic techniques, decreasing the usual lengths of stay associated with traditional surgery.

Programs & Specialties

Fact Sheets

News from Yale Medicine

In the News

Clinical Trials

Kidney Cancer, Melanoma

A Multicenter Phase 2 Trial to Evaluate Intracranial Response to Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma Who Are Anti-PD1/PD-L1 Experienced

Date8 February
Prostate Cancer

A Phase 1 Open-Label, Dose-Escalation Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARV-766 in Patients With Metastatic Castration-Resistant Prostate Cancer

Date24 March
Prostate Cancer

A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 509 in Subjects With Metastatic Castration-Resistant Prostate Cancer

Date21 March
Prostate Cancer, Bladder Cancer

A Phase 1, First-in-Human, Dose-Escalation and Expansion Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

Date20 December